Banner Image Banner Image

Investors
& Media

Press Releases

Press Releases

All Releases
TG Therapeutics to Participate in the B. Riley Securities 2022 Virtual Oncology Investor Conference
Fireside chat scheduled for 10:00 AM ET on Thursday, January 27, 2022 NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in a fireside chat during the B.
Jan 24, 2022
TG Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
Presentation scheduled for Monday January 10, 2022 at 9:45 AM ET NEW YORK, Jan. 05, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 40 th Annual J.P.
Jan 05, 2022
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
$70 million funded at closing NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that its existing term loan facility agreement with Hercules Capital, Inc. (NYSE: HTGC), has been amended to increase the size of the facility to $200 million, with $70
Jan 04, 2022
Displaying 21 - 23 of 23